T 0172/13 (Anti-VEGF antibodies/GENENTECH) of 29.11.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T017213.20161129
- Date of decision
- 29 November 2016
- Case number
- T 0172/13
- Petition for review of
- -
- Application number
- 04779660.2
- IPC class
- C12N 15/13C07K 16/00A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Anti-VEGF antibodies
- Applicant name
- Genentech, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 115European Patent Convention R 103(1)(a)
- Keywords
- Right to be heard - violation (yes)
Substantial procedural violation - (yes)
Remittal to the department of first instance (yes)
Observations by third parties - not considered in view of remittal
Reimbursement of appeal fee - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of the claim requests submitted with the statement of grounds of appeal.
3. The appeal fee is to be reimbursed.